Survival after Stereotactic Radiation Therapy


Age (years) :



Sex:


Charlson-Deyo Comorbidity Score:


Metastases:

Bone
Brain
Liver
Lung

Tumor Primary:


Radiotherapy Site:

Brain, eye
Head and neck, skin,
thyroid
Thorax
Stomach, liver, pancreas,
kidney, abdomen
Breast
Bone
Soft tissue
Pelvis
Other

Outcome Probability
1-year survival
5-year survival

Risk category: